|Awarded On||February 16, 2022|
|Title||AI-based conversational agent for facilitating education and communication about HPV vaccination in children and adolescents|
|Award Mechanism||Individual Investigator Research Awards for Cancer in Children and Adolescents|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||Cui Tao|
|Cancer Sites||Ovary, Penis, Vagina|
Human papillomavirus (HPV) infections cause about 34,000 cases of cancers every year in the U.S. The HPV vaccine is noted to be 99% effective against the HPV virus. One predictive study reported that if the population were to have 70% coverage of HPV vaccine, at least 4 million deaths worldwide could be prevented in the next decade.
For the HPV vaccine to be effective, patients need to complete the two to three dose series for the vaccine. Currently, the completion rates for the HPV vaccine for adolescents in the United States population is 48.6%, short of the 80% uptake goal. A number of factors affect a child's receipt of HPV vaccines, including parental awareness and provider recommenda...